+433,968.9%
NVDA vs CVS
+478.7%
+433,490.2%
-89.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.0% | -0.5% | -1.5% | -1.9% |
| 7D | -12.7% | +6.6% | -19.3% | -14.3% |
| 30D | -26.4% | -0.4% | -26.0% | -26.6% |
| 3M | -27.6% | -5.3% | -22.4% | -27.1% |
| 6M | -27.7% | -7.7% | -20.0% | -26.9% |
| YTD | -12.5% | +16.0% | -28.5% | -17.8% |
| 1Y | -12.6% | +16.2% | -28.9% | -18.1% |
| 3Y | +235.9% | +47.6% | +188.4% | +181.0% |
| 5Y | +438.2% | +12.3% | +425.9% | +386.5% |
| 10Y | +7,445.8% | +62.4% | +7,383.4% | +5,774.3% |
| All | +433,968.9% | +478.7% | +433,490.2% | +240,271.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling